Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
Titel:
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
Auteur:
Hurvitz, Sara A Andre, Fabrice Jiang, Zefei Shao, Zhimin Mano, Max S Neciosup, Silvia P Tseng, Ling-Min Zhang, Qingyuan Shen, Kunwei Liu, Donggeng Dreosti, Lydia M Burris, Howard A Toi, Masakazu Buyse, Marc E Cabaribere, David Lindsay, Mary-Ann Rao, Shantha Pacaud, Lida Bubuteishvili Taran, Tetiana Slamon, Dennis